Liquid Biopsy Market Key Highlights and Future Opportunities Till 2035

The global liquid biopsy market is poised for substantial growth, with its size projected to increase from USD 6.09 billion in 2024 to USD 29.8 billion by 2035, reflecting a compound annual growth rate (CAGR) of 15.53% during this period. This growth is primarily driven by the rising demand for non-invasive liquid biopsy products, fueled by an increasing focus on early cancer detection and patient monitoring.

Cancer remains a critical global health challenge, being the second leading cause of death worldwide. The World Health Organization estimates approximately 16.3 million cancer-related deaths by 2040. Among cancer types, breast cancer is the most common globally, followed by lung, colorectal, and prostate cancers. Early detection is crucial for improving treatment success and patient survival rates.

Read More :- https://www.rootsanalysis.com/....reports/liquid-biops

Virtual biopsy Market Trends, Sales, Supply, Demand and Analysis by Forecast to 2035
Biopsy is defined as a procedure of removing or extracting tissue from the body through various methods, such as surgical, needle, laparoscopic techniques.

The global virtual biopsy market, valued at USD 0.73 billion in 2024, is projected to reach USD 0.78 billion in 2025 and USD 3.02 billion by 2035, representing a CAGR of 14.47% during the forecast period.

https://www.rootsanalysis.com/....reports/virtual-biop

Biopsy is defined as a procedure of removing or extracting tissue from the body through various methods, such as surgical, needle, laparoscopic techniques.

The global virtual biopsy market, valued at USD 0.73 billion in 2024, is projected to reach USD 0.78 billion in 2025 and USD 3.02 billion by 2035, representing a CAGR of 14.47% during the forecast period.

This procedure plays a crucial role in the diagnosis or monitoring of certain medical conditions such as inflammatory disorders, immune disorders, oncological conditions, and several infections. By analyzing the cellular composition of the extracted tissue, healthcare experts can gain detailed insights into the patient’s condition. Despite its diagnostic importance, biopsy is an invasive technique which can cause pain, discomfort and may lead to severe complications, such as bleeding and infections. To mitigate these issues, advancements in medical technology have led to the development of less invasive techniques, such as virtual biopsy.
https://www.rootsanalysis.com/....reports/virtual-biop

Targeted drug delivery system Market - Current Impact to Make Big Changes by 2035

The prevalence of chronic diseases has increased significantly over the past few decades. Presently, around 129 million people in the US have at least one life threating chronic condition, such as heart disease, cancer, diabetes, obesity or hypertension.

The global targeted drug delivery device market size is projected to grow from $427 Million in 2026 to $2,153 Million by 2035, representing a CAGR of 19.7% during the forecast period.

Additionally, about 90% of the annual USD 4.1 trillion health care expenditure is attributed to managing and treating chronic diseases and mental health conditions. Thus, rising incidence of chronic diseases, coupled with aging population has led to a surge in the demand for novel drugs, including complex small molecules and biologics, across multiple therapeutic areas.

https://www.rootsanalysis.com/....reports/targeted-dru